Supply

Understanding the falsified medicines directive

9 March 2023An overview of the changes to the requirements for medicines ‘safety features’ following the UK’s departure from the EU

Continuing management of the ADHD medicines shortage

16 November 2023

Prescribing and ordering available pancreatic enzyme replacement therapies

17 July 2024

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021This article reflects MHRA guidance on the use of PGDs for medications which have risk minimisation measures (RMM).

Supply and/or administration of Controlled Drugs under a PGD

16 November 2021This article summarises the legal position on the supply and/or administration of controlled drugs under PGDs.

Using a Patient Group Direction to adjust doses of medicines

16 November 2021This article outlines why PGDs cannot be used to adjust the dosage of a medicine already in an individual's possession

Off label medicine use under a Patient Group Direction

10 June 2021This article explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off label')

Guidance on Managing The Sourcing and Supply of Ready-to-Administer Chemotheraphy Doses for the NHS (Yellow Cover)

5 December 2016This document is aimed at staff in UK NHS hospitals considering or already sourcing their supply of chemotherapy as ready-to-administer doses.

Unlicensed medicines and use of PGDs

16 November 2021This page explains why PGD are not legal mechanism for the administration or supply of unlicensed medicines.

Semi-acute settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in semi-acute settings

SPS - Specialist Pharmacy Service

NHS